Felice Marinosci
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 5
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 8
- Oncology top 10%
- Peptidase Inhibition and Analysis 5
- Pancreatic and Hepatic Oncology Research 2
-
- Liver Disease Diagnosis and Treatment 4
- Urinary Tract Infections Management 3
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Salvatore AntonaciGianluigi GiannelliEmilia FransveaCarlo BergaminiO SchiraldiL. LupoMichele QuarantaFlorenzo Iannone
- Journals
- Biochemical and Biophysical Research Communications (1 paper)American Journal Of Pathology (1 paper)International Journal of Cancer (3 papers)
- Partner nations
- ItalyUnited States
In The Last Decade
Felice Marinosci
23 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 93
- Hepatology 265
- Immunology and Allergy 163
- Cancer Research 341
- Oncology 273
- Molecular Biology 413
Countries citing papers authored by Felice Marinosci
This map shows the geographic impact of Felice Marinosci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felice Marinosci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felice Marinosci more than expected).
Fields of papers citing papers by Felice Marinosci
This network shows the impact of papers produced by Felice Marinosci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felice Marinosci. The network helps show where Felice Marinosci may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Felice Marinosci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 12 | |
| 2 | 2015 | 16 | |
| 3 | 2013 | 3 | |
| 4 | 2007 | 79 | |
| 5 | Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis. | 2006 | 1 |
| 6 | 2006 | 11 | |
| 7 | 2006 | 16 | |
| 8 | 2005 | 8 | |
| 9 | 2005 | 54 | |
| 10 | 2005 | 50 | |
| 11 | 2005 | 50 | |
| 12 | 2005 | 36 | |
| 13 | 2002 | 133 | |
| 14 | 2002 | 24 | |
| 15 | 2002 | 16 | |
| 16 | 2001 | 124 | |
| 17 | 2001 | 168 | |
| 18 | 2000 | 42 | |
| 19 | [Study on the mechanism of action of 2 intraocular hypotensive agents: ergotamine and propranolol]. | 1969 | 1 |
| 20 | [On the effects of oral administration of propylene glycol, as an ocular osmotic hypotonic agent, on the cardiocirculatory system]. | 1969 | 1 |
About Felice Marinosci
Felice Marinosci is a scholar working on Immunology and Allergy, Hepatology and Cancer Research, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (5 papers), Cell Adhesion Molecules Research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Urinary Tract Infections Management (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (265 citations), Immunology and Allergy (163 citations) and Cancer Research (341 citations). Felice Marinosci has collaborated with scholars based in Italy and United States. Frequent co-authors include Salvatore Antonaci, Gianluigi Giannelli, Emilia Fransvea, Carlo Bergamini, O Schiraldi, L. Lupo, Michele Quaranta, Florenzo Iannone, P Dentico and Giovanni Lapadula. Their work appears in journals such as Biochemical and Biophysical Research Communications, American Journal Of Pathology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.